Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT00165412 Completed - Breast Cancer Clinical Trials

Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease

Start date: July 2005
Phase:
Study type: Observational

The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.

NCT ID: NCT00165308 Completed - Breast Cancer Clinical Trials

Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

Start date: April 2001
Phase: N/A
Study type: Interventional

The purpose of this study is determine whether or not tamoxifen reduces the chance of Hodgkin's Disease survivors developing breast cancer.

NCT ID: NCT00165204 Completed - Breast Cancer Clinical Trials

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

Start date: April 2004
Phase: Phase 2
Study type: Interventional

Women undergoing surgical menopause often experience marked menopausal side effects but are reluctant to use estrogen or other female hormones to ease the transition to menopause because of worries that the hormones may increase breast cancer risks. This study will evaluate tibolone in women experiencing surgical menopause to assess its effects on bone health, menopause symptoms and breast density.

NCT ID: NCT00165152 Completed - Breast Cancer Clinical Trials

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Start date: July 1998
Phase: N/A
Study type: Interventional

To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.

NCT ID: NCT00164658 Completed - Breast Cancer Clinical Trials

Evaluating Tools for Health Promotion and Disease Prevention

Start date: September 2005
Phase: Phase 1
Study type: Interventional

The study will evaluate the effect of familial risk assessment and prevention prompts tailored to familial risk on health behaviors and use of preventive services among adults who are members of primary care practices in the U.S.

NCT ID: NCT00161980 Completed - Breast Cancer Clinical Trials

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Start date: June 2001
Phase: Phase 3
Study type: Interventional

This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing the axillary lymphatics in subjects undergoing lumpectomy and level I and II axillary lymph node dissection with two separate incisions.

NCT ID: NCT00161291 Completed - Breast Cancer Clinical Trials

Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer

Start date: June 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine pathological response to a maximum of 18 weeks of neoadjuvant therapy using a combination of letrozole and Bevacizumab in post-menopausal women with pathologically confirmed invasive ductal cancer or invasive lobular cancer of the breast whose tumors are hormone positive.

NCT ID: NCT00161265 Completed - Breast Cancer Clinical Trials

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Start date: May 2005
Phase: N/A
Study type: Observational

This study is being performed so that tumor and blood samples from patients who will receive breast cancer treatment prior to surgery can be collected and stored for future research.

NCT ID: NCT00160901 Completed - Breast Cancer Clinical Trials

Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer

Start date: August 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine wether a complementary therapy consisting of a combined medication of selenium, milk thistle, goldenrod and bromelain and a consultation concerning nutrition and physical activity can reduce side effects of a chemotherapy in breast cancer patients.

NCT ID: NCT00156806 Completed - Breast Cancer Clinical Trials

Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.

Start date: March 2002
Phase: Phase 3
Study type: Interventional

Breast cancer treatment often involved radiation to the breast. A side-effect of this treatment is skin redness, itching and burning. Some patients have quite severe reactions. Our current treatment for this is to avoid any soaps or other skin irritants and to use a moisturizing cream once all radiation is finished. Aloe vera is believed by many people to be useful for treatment of skin burns but this has never been proven in a randomized study. The aim of this study is to compare aloe vera gel versus plan gel versus the standard treatment to determine if there is any benefit. If there was a benefit of gel treatment over standard it could make radiation treatments more tolerable for cancer patients.